丙酸氯倍他索诱发未确诊2型糖尿病患者的刺激性接触性皮炎
Irritant Contact Dermatitis Induced by Compound Clobetasol Propionate in a Patient with Undiagnosed Type 2 Diabetes Mellitus.
作者信息
Ge Xiaopei, Hao Pingsheng, Chen Xinlong
机构信息
Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China.
出版信息
Clin Cosmet Investig Dermatol. 2025 Aug 28;18:2035-2037. doi: 10.2147/CCID.S544591. eCollection 2025.
Irritant contact dermatitis (ICD) is a common inflammatory skin condition caused by direct cytotoxic effects of irritants on the epidermis. Topical corticosteroids, while effective for treating inflammatory dermatoses, may paradoxically induce adverse skin reactions when misused. This case highlights ICD triggered by self-administration of compound clobetasol propionate ointment, exacerbated by undiagnosed type 2 diabetes mellitus (T2DM).
刺激性接触性皮炎(ICD)是一种常见的炎症性皮肤病,由刺激物对表皮的直接细胞毒性作用引起。局部用皮质类固醇虽然对治疗炎症性皮肤病有效,但滥用时可能会反常地引起皮肤不良反应。本病例强调了自行使用复方丙酸氯倍他索软膏引发的ICD,并因未诊断出的2型糖尿病(T2DM)而加重。
相似文献
Clin Cosmet Investig Dermatol. 2025-8-28
Cochrane Database Syst Rev. 2023-8-11
Cochrane Database Syst Rev. 2018-4-30
Cochrane Database Syst Rev. 2011-12-7
Cochrane Database Syst Rev. 2015-7-1
Am J Clin Dermatol. 2009
Cochrane Database Syst Rev. 2016-11-7
Int Arch Occup Environ Health. 2022-1
本文引用的文献
Antiinflamm Antiallergy Agents Med Chem. 2024
Curr Dermatol Rep. 2022
J Diabetes Investig. 2021-12
J Allergy Clin Immunol. 2012-8-28
Drugs Today (Barc). 2008-7
Australas J Dermatol. 2008-2